SCHEMBL7183765

SCHEMBL7183765

N#Cc1ccc2c(c1)n(Cc1ccc(Cl)c(Cl)c1)c(=O)n2C1CCC(O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTHFD2 P13995 1/20 0.40
CCR2 P41597 4/20 0.39
OPRM1 P35372 3/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HRH1 P35367 2/20 0.38
CCR3 P51677 2/20 0.38
SRC P12931 1/20 0.37
PRKACA P17612 1/20 0.37
PRKACG P22612 1/20 0.37
PRKACB P22694 1/20 0.37
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
C5AR1 P21730 3/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7183760 1.00 MTHFD2 (0.40) MTHFD2CCR2OPRM1LMNAGAA
SCHEMBL7188682 0.91 CYP3A4 (0.42) CCR2OPRM1PRMT5WDR77C5AR1
SCHEMBL7188706 0.91 CYP3A4 (0.42) CCR2OPRM1PRMT5WDR77C5AR1
SCHEMBL7182967 0.89 PDE7A (0.44) PRMT5WDR77C5AR1
SCHEMBL7185263 0.89 PDE5A (0.47) PRMT5WDR77
SCHEMBL7182960 0.89 PDE7A (0.44) PRMT5WDR77C5AR1
SCHEMBL7178544 0.89 PDE5A (0.47) PRMT5WDR77
SCHEMBL7178553 0.89 PDE5A (0.47) PRMT5WDR77
SCHEMBL7191279 0.87 DRD4 (0.43) LMNAGAAMAPTHTTSMN1; SMN2
SCHEMBL7191286 0.87 DRD4 (0.43) LMNAGAAMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6582351-B1 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-24 US disclosed